Abstract: The invention provides isolated nucleic acid compounds encoding a multiple drug resistance protein of Aspergillus fumigatus. Vectors and transformed host cells comprising the multiple drug resistance-encoding DNA of Aspergillus fumigatus AfuMDR1 are also provided. The invention further provides assays which utilize these transformed host cells.
Type:
Grant
Filed:
March 8, 1996
Date of Patent:
June 22, 1999
Assignee:
Eli Lilly and Company
Inventors:
Robert Brown Peery, Paul Luther Skatrud, Matthew Barry Tobin